Associate Professor Roderick Clifton-Bligh

BSC (med) MB BS (hons) FRACP PhD FFSc (RCPA)
Associate Professor
Medicine, Northern Clinical School
Kolling Institute of Medical Research

Telephone 02 99268388
Fax 02 99067525

Map

Biographical details

A/Prof Roderick Clifton-Bligh is Head of the Department of Endocrinology at Royal North Shore Hospital, and conjoint associate professor in Medicine at the University of Sydney. He completed a PhD in the genetics of thyroid disorders at the University of Cambridge. He now supervises dual research groups, one of which focuses on the genetics of endocrine neoplasms, and the other on metabolic bone disease.

Research interests

The Cancer Genetics Unit studies the molecular bases of thyroid cancer, phaechromocytoma/paraganglioma syndromes, adrenal cancer, and pituitary neoplasms. The Metabolic Bone Research Unit studies calcium-sensing receptor gene mutations and FGF23 biology.His scope of clinical practice remains broad. He has co-supervised 8 completed PhDs, including five Endocrinologists. He maintains a strong involvement in teaching and mentoring young physicians.

Current projects

1.HEREDITARY ENDOCRINE CANCER: A MODEL BASED ON PHAEOCHROMOCYTOMA- PARAGANGLIOMA SYNDROMES

2.TRANSCRIPTION FACTOR FOXE1 AND THYROID CANCER

3. THE ROLE OF TERT IN THYROID CANCER AND OTHER ENDOCRINE NEOPLASMS

4.Overcoming barriers to Osteoporosis Treatment Using Fracture Risk Calculators

Associations

Endocrine Society of Australia

Australia and New Zealand Bone and Mineral Society

The Endocrine Society (US)

American Bone and Mineral Society

Awards and honours

NSW Premier’s Award for Excellence in Translational Cancer Research (2013)

Asia and Oceania Thyroid Association Nagataki-Fujifilm Prize (2014)

Clinical Specialty

Endocrinology

PhD and master's project opportunities

Selected grants

2015

  • Gene Interactions in Hereditary Cancer: A Model Based on Phaeochromocytoma-Paraganglioma Syndromes; Clifton-Bligh R; DVC Research/Bridging Support Grant.

2014

  • Do human pituitary adenomas demonstrate an increased expression of Corticotropin Releasing Factor (CRF) receptors?; Bailey D, Clifton-Bligh R; Australian Institute of Nuclear Science and Engineering (AINSE)/Research Grants.
  • Foxe1 and Thyroid Cancer; Clifton-Bligh R, Walsh J; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • 2013 Premiers Award for Excellence in Translational Cancer Research; Gill A, Clifton-Bligh R; Cancer Institute New South Wales/Premier's Award.

2012

  • The Australasian Succinate Dehydrogenase Consortium; Dwight T, Clifton-Bligh R, Benn D, Robinson B; Pheo Para Alliance/Project grant.
  • Mitochondrial Dysfunction and Hypoxic Responses: Implications for Tumorigenesis; Dwight T, Clifton-Bligh R, Benn D, Robinson B; Pheo Para Alliance/Project grant.

2011

  • Translating molecular markers to clinical practice in thyroid cancer; Clifton-Bligh R; DVC Research/Cancer Research Fund.

2008

  • Cross-talk between PPARg and MAP kinase pathways in thyroid cancer; Clifton-Bligh R, Au A, Learoyd D, Robinson B; Cancer Council New South Wales/Research Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Gild, M., Clifton-Bligh, R., Robinson, B. (2013). Multiple Endocrine Neoplasia Type 2 and Bone. In Rajesh V Thakker, Michael P Whyte, John A Eisman, Takashi Igarashi (Eds.), Genetics of Bone Biology and Skeletal Disease, (pp. 505-513). London, United Kingdom: Academic Press.
  • Clifton-Bligh, R., Delbridge, L. (2005). Thyroid Physiology. In Clark, Orlo H.; Duh, Quan-Yang; Kebebew, Electron (Eds.), Textbook of endocrine surgery (2nd ed.). Philadelphia: Saunders Elsevier.

Journals

  • Cole, A., Dwight, T., Gill, A., Dickson, K., Zhu, Y., Clarkson, A., Gard, G., Maidens, J., Valmadre, S., Clifton-Bligh, R., Marsh, D. (2016). Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Scientific Reports, 6, 1-12. [More Information]
  • Rothberg, L., Lees, T., Clifton-Bligh, R., Lal, S. (2016). Association Between Heart Rate Variability Measures and Blood Glucose Levels: Implications for Noninvasive Glucose Monitoring for Diabetes. Diabetes Technology and Therapeutics, 18(6), 366-376. [More Information]
  • Fraser, S., Go, C., Aniss, A., Sidhu, S., Delbridge, L., Learoyd, D., Clifton-Bligh, R., Tacon, L., Tsang, V., Robinson, B., Gill, A., Sywak, M. (2016). BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer. World Journal of Surgery, 40(7), 1618-1624. [More Information]
  • Gild, M., Bullock, M., Pon, C., Robinson, B., Clifton-Bligh, R. (2016). Destabilizing RET in targeted treatment of thyroid cancers. Endocrine Connections, 5(1), 10-19. [More Information]
  • Shi, X., Lui, R., Basolo, F., Giannini, R., Shen, X., Teng, D., Guan, H., Shan, Z., Teng, W., Musholt, T., O'Neill, C., Sywak, M., Clifton-Bligh, R., et al (2016). Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. Journal of Clinical Endocrinology and Metabolism, 101(1), 264-274. [More Information]
  • Harrison, W., Andrici, J., Maclean, F., Madadi-Ghahan, R., Farzin, M., Sioson, L., Toon, C., Clarkson, A., Watson, N., Pickett, J., Goodwin, A., Anderson, L., Clifton-Bligh, R., Dwight, T., Gill, A., et al (2016). Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings. American Journal of Surgical Pathology, 40(5), 599-607. [More Information]
  • McGrath, R., Preda, V., Clifton-Bligh, P., Robinson, B., Sywak, M., Delbridge, L., Ward, P., Clifton-Bligh, R., Learoyd, D. (2016). Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies? A large (Australian) cohort study in differentiated thyroid cancer. Clinical Endocrinology, 84(2), 271-277. [More Information]
  • Annamalai, A., Sampathkumar, K., Kane, S., Shetty, N., Kulkarni, S., Rangarajan, V., Purandare, N., Pai, P., Mahuvakar, A., et al, Gill, A., Clifton-Bligh, R. (2016). Needle(s) in the haystack- synchronous multifocal tumor induced osteomalacia. Journal of Clinical Endocrinology and Metabolism, 101(2), 390-393. [More Information]
  • Flynn, A., Dwight, T., Harris, J., Benn, D., Zhou, L., Hogg, A., Catchpoole, D., James, P., Duncan, E., Trainer, A., Gill, A., Clifton-Bligh, R., et al (2016). Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 101(4), 1034-1043. [More Information]
  • Martinez-Aguilar, J., Clifton-Bligh, R., Molloy, M. (2016). Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy. Scientific Reports, 6, 1-12. [More Information]
  • Bullock, M., Ren, Y., O’Neill, C., Gill, A., Aniss, A., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., de Vathaire, F., Robinson, B., Clifton-Bligh, R. (2016). TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas. Clinical Endocrinology, 85(2), 283-290. [More Information]
  • Benn, D., Robinson, B., Clifton-Bligh, R. (2015). 15 Years of Paraganglioma: Clinical manifestations of paraganglioma syndromes types 1-5. Endocrine-Related Cancer, 22(4), T91-T103. [More Information]
  • Chou, A., Fraser, S., Toon, C., Clarkson, A., Sioson, L., Farzin, M., Cussigh, C., Aniss, A., O'Neill, C., Watson, N., Clifton-Bligh, R., Learoyd, D., Robinson, B., Delbridge, L., Sidhu, S., O'Toole, S., Sywak, M., Gill, A., et al (2015). A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma. American Journal of Surgical Pathology, 39(5), 652-659. [More Information]
  • Martinez-Aguilar, J., Clifton-Bligh, R., Molloy, M. (2015). A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours. BMC Cancer, 15(1), 1-14. [More Information]
  • Xing, M., Alzahrani, A., Carson, K., Shong, Y., Kim, T., Viola, D., Elisei, R., Bendlova, B., Yip, L., Mian, C., O'Neill, C., Sywak, M., Clifton-Bligh, R., et al (2015). Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer. Journal of Clinical Oncology, 33(1), 42-50. [More Information]
  • Cole, A., Clifton-Bligh, R., Marsh, D. (2015). Histone H2B monoubiquitination - roles to play in human malignancy. Endocrine-Related Cancer, 22(1), T19-T33. [More Information]
  • Elston, M., Meyer-Rochow, G., Conaglen, H., Clarkson, A., Clifton-Bligh, R., Conaglen, J., Gill, A. (2015). Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas. Human Pathology, 46(3), 390-396. [More Information]
  • Gundara, J., Gill, A., Glover, A., Benson, K., Clifton-Bligh, R., Roxburgh, S., Sywak, M. (2015). Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluation. ANZ Journal of Surgery, 85(4), 289-290. [More Information]
  • Clifton-Bligh, P., Nery,, M., Clifton-Bligh, R., Visvalingam, S., Fulcher, G., Byth Wilson, K., Baber, R. (2015). Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition, 69(1), 134-142. [More Information]
  • Papathomas, T., Oudijk, L., Persu, A., Gill, A., van Nederveen, F., Tischler, A., Tissier, F., volante, M., Matias-Guiu, X., Smid, M., Clifton-Bligh, R., et al (2015). SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Modern Pathology, 28(6), 807-821. [More Information]
  • Mond, M., Bullock, M., Yao, Y., Clifton-Bligh, R., Gilfillan, C., Fuller, P. (2015). Somatic Mutations of FOXE1 in Papillary Thyroid Cancer. Thyroid, 25(8), 904-910. [More Information]
  • Kim, E., Rath, E., Tsang, V., Duff, A., Robinson, B., Church, W., Benn, D., Dwight, T., Clifton-Bligh, R. (2015). Structural and functional consequences of succinate dehydrogenase subunit B mutations. Endocrine-Related Cancer, 22(3), 387-397. [More Information]
  • Flynn, A., Benn, D., Clifton-Bligh, R., Robinson, B., Trainer, A., James, P., Hogg, A., Waldeck, K., George, J., Li, J., Gill, A., et al (2015). The genomic landscape of phaeochromocytoma. Journal of Pathology, 236(1), 78-89. [More Information]
  • Girgis, C., Cha, K., Houweling, P., Rao, R., Mokbel, N., Lin, M., Clifton-Bligh, R., Gunton, J. (2015). Vitamin D Receptor Ablation and Vitamin D Deficiency Result in Reduced Grip Strength, Altered Muscle Fibers, and Increased Myostatin in Mice. Calcified Tissue International, 97(6), 602-610. [More Information]
  • Thompson, A., Turner, R., Hayen, A., Ahmad, A., Jalaty, S., Learoyd, D., Sidhu, S., Delbridge, L., Yeh, M., Clifton-Bligh, R., Sywak, M. (2014). A Pre-operative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer. Thyroid, 24(4), 675-682. [More Information]
  • Schlosberg, A., Lam, B., Yeo, G., Clifton-Bligh, R. (2014). DEFLATE Compression Algorithm Corrects for Overestimation of Phylogenetic Diversity by Grantham Approach to Single-Nucleotide Polymorphism Classification. International Journal of Molecular Sciences, 15(5), 8491-8508. [More Information]
  • Lin, R., Gallagher, R., Spinaze, M., Najoumian, H., Dennis, C., Clifton-Bligh, R., Tofler, G. (2014). Effect of a Patient-Directed Discharge Letter on Patient Understanding of their Hospitalisation. Internal Medicine Journal, 44(9), 851-857. [More Information]
  • Girgis, C., Clifton-Bligh, R., Turner, N., Lau, S., Gunton, J. (2014). Effects of Vitamin D in Skeletal Muscle: Falls, Strength, Athletic Performance and Insulin Sensitivity. Clinical Endocrinology, 80(2), 169-181. [More Information]
  • Glendenning, P., Bell, D., Clifton-Bligh, R. (2014). Investigating hypophosphataemia. BMJ, 348, g3172. [More Information]
  • Gundara, J., Zhao, J., Gill, A., Clifton-Bligh, R., Robinson, B., Delbridge, L., Sidhu, S. (2014). Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ Journal of Surgery, 84(4), 235-239. [More Information]
  • Tsang, V., Dwight, T., Benn, D., Meyer-Rochow, G., Gill, A., Sywak, M., Sidhu, S., Veivers, D., Sue, C., Robinson, B., Clifton-Bligh, R., Parker, N. (2014). Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Endocrine-Related Cancer, 21(3), 415-426. [More Information]
  • Kruijff, S., Petersen, J., Chen, P., Aniss, A., Clifton-Bligh, R., Sidhu, S., Delbridge, L., Gill, A., Learoyd, D., Sywak, M. (2014). Patterns of Structural Recurrence in Papillary Thyroid Cancer. World Journal of Surgery, 38(3), 653-659. [More Information]
  • Parker, R., Clifton-Bligh, R., Molloy, M. (2014). Phosphoproteomics of MAPK inhibition in BRAF mutated cells and a role for the lethal synergism of dual BRAF and CK2 inhibition. Molecular Cancer Therapeutics, 13(7), 1894-1906. [More Information]
  • Paik, J., Toon, C., Benn, D., High, H., Hasovitz, C., Pavlakis, N., Clifton-Bligh, R., Gill, A. (2014). Renal Carcinoma Associated With Succinate Dehydrogenase B Mutation: A New and Unique Subtype of Renal Carcinoma. Journal of Clinical Oncology, 32(6), e10-e13. [More Information]
  • Gill, A., Hes, O., Papathomas, T., Šedivcová, M., Tan, P., Agaimy, A., Andresen, P., Kedziora, A., Clarkson, A., Toon, C., Sioson, L., Clifton-Bligh, R., Robinson, B., Benn, D., et al (2014). Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients. The American Journal of Surgical Pathology, 38(12), 1588-1602. [More Information]
  • Gill, A., Toon, C., Clarkson, A., Sioson, L., Chou, A., Winship, I., Robinson, B., Benn, D., Clifton-Bligh, R., Dwight, T. (2014). Succinate dehydrogenase deficiency is rare in pituitary adenomas. American Journal of Surgical Pathology, 38(4), 560-566. [More Information]
  • Girgis, C., Mokbel, N., Cha, K., Houweling, P., Abboud, M., Fraser, D., Mason, R., Clifton-Bligh, R., Gunton, J. (2014). The Vitamin D receptor (VDR) is Expressed in Skeletal Muscle of Male Mice and Modulates 25- Hydroxyvitamin D (25OHD) Uptake in myofibres. Endocrinology, 155(9), 3227-3237. [More Information]
  • Girgis, C., Clifton-Bligh, R., Mokbel, N., Cheng, K., Gunton, J. (2014). Vitamin D Signaling Regulates Proliferation, Differentiation and Myotube Size in C2C12 Skeletal Muscle Cells. Endocrinology, 155(2), 347-357. [More Information]
  • McInerney-Leo, A., Marshall, M., Gardiner, B., Benn, D., McFarlane, J., Robinson, B., Brown, M., Leo, P., Clifton-Bligh, R., Duncan, E. (2014). Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas. Clinical Endocrinology, 80(1), 25-33. [More Information]
  • Xing, M., Alzahrani, A., Carson, K., Viola, D., Elisei, R., Bendlova, B., Yip, L., Mian, C., Vianello, F., Tuttle, M., O'Neill, C., Sywak, M., Clifton-Bligh, R., et al (2013). Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA, 309(14), 1493-1501. [More Information]
  • Kruijff, S., Aniss, A., Chen, P., Sidhu, S., Delbridge, L., Robinson, B., Clifton-Bligh, R., Roach, P., Gill, A., Learoyd, D., Sywak, M. (2013). Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery, 154(6), 1337-1345. [More Information]
  • Clifton-Bligh, R. (2013). Diagnosis of silent pheochromocytoma and paraganglioma. Expert Review of Endocrinology & Metabolism, 8(1), 47-57. [More Information]
  • Dwight, T., Mann, K., Benn, D., Robinson, B., McKelvie, P., Gill, A., Winship, I., Clifton-Bligh, R. (2013). Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 98(6), E1103-E1108. [More Information]
  • Gill, A., Lipton, L., Taylor, J., Benn, D., Richardson, A., Frydenberg, M., Shapiro, J., Clifton-Bligh, R., Chow, C., Bogwitz, M. (2013). Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma. Pathology, 45(7), 689-691. [More Information]
  • Clifton-Bligh, R., Hofman, M., Duncan, E., Sim, L., Darnell, D., Clarkson, A., Wong, T., Walsh, J., Gill, A., Ebeling, P., et al (2013). Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET/CT. Journal of Clinical Endocrinology and Metabolism, 98(2), 687-694. [More Information]
  • Dwight, T., Benn, D., Clarkson, A., Vilain, R., Lipton, L., Robinson, B., Clifton-Bligh, R., Gill, A. (2013). Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology, 37(2), 226-233. [More Information]
  • Ding, L., Shankara-Narayana, N., Wood, C., Ward, P., Sidhu, S., Clifton-Bligh, R. (2013). Markedly Elevated Serum Thyroglobulin Associated with Heterophile Antibodies: A Cautionary Tale. Thyroid, 23(6), 771-772. [More Information]
  • McCormack, A., Kaplan, W., Gill, A., Little, N., Cook, R., Robinson, B., Clifton-Bligh, R. (2013). MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary, 16(2), 208-219. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Glover, A., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2013). MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer, 119(24), 4358-4365. [More Information]
  • Houang, M., Clarkson, A., Sioson, L., Elston, M., Clifton-Bligh, R., Dray, M., Ranchere-Vince, D., Decouvelaere, A., de la Fouchardiere, A., Gill, A. (2013). Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Human Pathology, 44(12), 2711-2718. [More Information]
  • Girgis, C., Clifton-Bligh, R., Hamrick, M., Holick, M., Gunton, J. (2013). The Roles of Vitamin D in Skeletal Muscle: Form, Function, and Metabolism. Endocrine Reviews, 34(1), 33-83. [More Information]
  • Bullock, M., Duncan, E., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Ludgate, M., Clifton-Bligh, R. (2012). Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 97(9), e1814-e1819. [More Information]
  • Nguyen, T., Eisman, J., Center, J., Pocock, N., Jones, G., March, L., Clifton-Bligh, R., Naganathan, V., Seibel, M. (2012). In Memoriam: Philip Neil Sambrook. Osteoporosis International, 23(7), 1835-1836. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2012). Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Annals of Surgical Oncology, 19(13), 4210-4216. [More Information]
  • Jorgensen, N., Husted, L., Skarratt, K., Stokes, L., Tofteng, C., Kvist, T., Jensen, J., Eiken, P., Brixen, K., Fuller, S., Clifton-Bligh, R., Wiley, J., et al (2012). Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. European Journal of Human Genetics, 20(6), 675-681. [More Information]
  • Chou, A., Chen, J., Clarkson, A., Samra, J., Clifton-Bligh, R., Hugh, T., Gill, A. (2012). Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Modern Pathology, 25(9), 1307-1313. [More Information]
  • Bullock, M., O'Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]
  • Clifton-Bligh, R., Nguyen, T., Au, A., Bullock, M., Cameron, I., Cumming, R., Chen, J., March, L., Seibel, M., Sambrook, P. (2011). Contribution of a Common Variant in the Promoter of the 1-a-Hydroxylase Gene (CYP27B1) to Fracture Risk in the Elderly. Calcified Tissue International, 88(2), 109-116. [More Information]
  • Tacon, L., Prichard, R., Soon, P., Robinson, B., Clifton-Bligh, R., Sidhu, S. (2011). Current and Emerging Therapies for Advanced Adrenocortical Carcinoma. The Oncologist, 16(1), 36-48. [More Information]
  • Gild, M., Bullock, M., Robinson, B., Clifton-Bligh, R. (2011). Multikinase inhibitors: a new option for the treatment of thyroid cancer. Nature Reviews Endocrinology, 7(10), 617-624. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clifton-Bligh, R. (2011). Pediatric-Type" Gastrointestinal Stromal Tumors Are SDHB Negative ("Type 2") GISTs.". American Journal of Surgical Pathology, 35(8), 1245-1247. [More Information]
  • Benaderet, A., Burton, A., Clifton-Bligh, R., ASHRAF, A. (2011). Primary Hyperparathyroidism with Low Intact PTH Levels in a 14-Year-Old Girl. Journal of Clinical Endocrinology and Metabolism, 96(8), 2325-2329. [More Information]
  • Gill, A., Pachter, N., Clarkson, A., Tucker, K., Winship, I., Benn, D., Robinson, B., Clifton-Bligh, R. (2011). Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. The New England Journal of Medicine, 364(9), 885-886. [More Information]
  • Gill, A., Pachter, N., Chou, A., Young, B., Clarkson, A., Tucker, K., Winship, I., Earls, P., Benn, D., Robinson, B., Clifton-Bligh, R., et al (2011). Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology. American Journal of Surgical Pathology, 35(10), 1578-1585. [More Information]
  • O'Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]
  • Gill, A., Benn, D., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G., Richardson, A., Sidhu, S., Robinson, B., Clifton-Bligh, R. (2010). Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Human Pathology, 41(6), 805-814. [More Information]
  • Abraham, D., Delbridge, L., Clifton-Bligh, R., Clifton-Bligh, P., Grodski, S., Robinson, B., Messina, M., Sidhu, S. (2010). Medullary thyroid carcinoma presenting with an initial CEA elevation. ANZ Journal of Surgery, 80(11), 831-833. [More Information]
  • Meyer-Rochow, G., Jackson, N., Conaglen, J., Whittle, D., Kunnimalaiyaan, M., Chen, H., Westin, G., Sandgren, J., Stalberg, P., Khanafshar, E., Gill, A., Clifton-Bligh, R., Robinson, B., Benn, D., Sidhu, S., et al (2010). MicroRNA profiling of benign and malignant pheochromocytoma identifies novel diagnostic and therapeutic targets. Endocrine-Related Cancer, 17(3), 835-846. [More Information]
  • Elston, M., Clifton-Bligh, R., Robinson, B. (2009). Familial pituitary tumor syndromes. Nature Reviews Endocrinology, 5(8), 453-61. [More Information]
  • McCormack, A., McDonald, K., Gill, A., Clark, S., Burt, M., Campbell, K., Braund, W., Little, N., Cook, R., Grossman, A., Robinson, B., Clifton-Bligh, R. (2009). Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clinical Endocrinology, 71(2), 226-233. [More Information]
  • Soon, P., Tacon, L., Gill, A., Bambach, C., Sywak, M., Campbell, P., Yeh, M., Wong, S., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research, 15(24), 7684-7692. [More Information]
  • Jack, M., Stone, M., Clifton-Bligh, R. (2009). Neonatal hypercalcemia due to polymorphisms of the calcium sensing receptor. Journal Of Pediatric Endocrinology and Metabolism, 22(6), 561-563. [More Information]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. (2009). Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas. Journal of Clinical Endocrinology and Metabolism, 94(4), 1436-1442. [More Information]
  • Meyer-Rochow, G., Soon, P., Delbridge, L., Sywak, M., Bambach, C., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ Journal of Surgery, 79(5), 367-370. [More Information]
  • Tacon, L., Soon, P., Gill, A., Chou, A., Clarkson, A., Botling, J., Stalberg, P., Skogseid, B., Robinson, B., Sidhu, S., Clifton-Bligh, R. (2009). The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 94(11), 4591-4599. [More Information]
  • Lee, J., Au, A., Foukakis, T., Barbaro, M., Kiss, N., Clifton-Bligh, R., Staaf, J., Borg, A., Delbridge, L., Robinson, B., et al (2008). Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocrine-Related Cancer, 15(3), 801-815. [More Information]
  • Au, A., McDonald, K., Gill, A., Sywak, M., Diamond, T., Conigrave, A., Clifton-Bligh, R. (2008). PTH Mutation with Primary Hyperparathyroidism and Undetectable Intact PTH. New England Journal of Medicine, 359(11), 1184-1186. [More Information]
  • Giordano, T., Au, A., Kuick, R., Thomas, D., Rhodes, D., Wilhelm, Jr., K., Vinco, M., Misek, D., Sanders, D., Zhu, Z., Clifton-Bligh, R., Robinson, B., et al (2006). Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical Cancer Research, 12(7), 1983-1993.
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. (2006). Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone, 39(2), 369-376. [More Information]
  • Au, A., McBride, C., Wilhelm, Jr., K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. (2006). PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology, 147(1), 367-376. [More Information]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. (2006). The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR gamma fusion. Journal of Clinical Endocrinology and Metabolism, 91(3), 1143-1149. [More Information]
  • Mun, H., Culverston, E., Franks, A., Collyer, C., Clifton-Bligh, R., Conigrave, A. (2005). A double mutation in the extracellular Ca2+-sensing receptor's venus flytrap domain that selectively disables L-amino acid sensing. Journal of Biological Chemistry, 280(32), 29067-29072. [More Information]
  • Xue, M., Thompson, P., Clifton-Bligh, R., Fulcher, G., Gallery, E., Jackson, C. (2005). Leukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetes. The International Journal of Biochemistry and Cell Biology, 37(11), 2406-2416. [More Information]
  • Veitch, P., Clifton-Bligh, R. (2004). Long-acting sulfonylureas - long-acting hypoglycaemia. Medical Journal of Australia, 180(2), 84-85.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Nelson, A., Clifton-Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jueppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., et al (2003). Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. Journal of Clinical Endocrinology and Metabolism, 88(9), 4088-4094.

Conferences

  • Tsang, V., Parker, N., Cassano, J., Dwight, T., Sue, C., Veivers, D., Robinson, B., Benn, D., Clifton-Bligh, R. (2012). Interaction between hypoxia and mutations in the SDH subunit genes associated with phaeochromocytoma/paragangliomas. 2012 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology, Gold Coast, Queensland, Australia.
  • Lin, R., Tofler, G., Spinaze, M., Dennis, C., Clifton-Bligh, R., Nojoumian, H., Gallagher, R. (2012). Patient-Directed Discharge Letter (PADDLE) - A Simple and brief intervention to improve patient knowledge and understanding at time of hospital discharge. 60th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ) 2012, Brisbane, Queensland, Australia. [More Information]
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Nelson, A., Coyle, L., Ward, C., Clifton-Bligh, R., Robinson, B., Mason, R. (2005). Elevated serum FGF23 concentrations in plasma cell dyscrasias. 27th Annual Meeting of the American Society for Bone and Mineral Research, United States: American Society for Bone and Mineral Research.

2016

  • Cole, A., Dwight, T., Gill, A., Dickson, K., Zhu, Y., Clarkson, A., Gard, G., Maidens, J., Valmadre, S., Clifton-Bligh, R., Marsh, D. (2016). Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Scientific Reports, 6, 1-12. [More Information]
  • Rothberg, L., Lees, T., Clifton-Bligh, R., Lal, S. (2016). Association Between Heart Rate Variability Measures and Blood Glucose Levels: Implications for Noninvasive Glucose Monitoring for Diabetes. Diabetes Technology and Therapeutics, 18(6), 366-376. [More Information]
  • Fraser, S., Go, C., Aniss, A., Sidhu, S., Delbridge, L., Learoyd, D., Clifton-Bligh, R., Tacon, L., Tsang, V., Robinson, B., Gill, A., Sywak, M. (2016). BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer. World Journal of Surgery, 40(7), 1618-1624. [More Information]
  • Gild, M., Bullock, M., Pon, C., Robinson, B., Clifton-Bligh, R. (2016). Destabilizing RET in targeted treatment of thyroid cancers. Endocrine Connections, 5(1), 10-19. [More Information]
  • Shi, X., Lui, R., Basolo, F., Giannini, R., Shen, X., Teng, D., Guan, H., Shan, Z., Teng, W., Musholt, T., O'Neill, C., Sywak, M., Clifton-Bligh, R., et al (2016). Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. Journal of Clinical Endocrinology and Metabolism, 101(1), 264-274. [More Information]
  • Harrison, W., Andrici, J., Maclean, F., Madadi-Ghahan, R., Farzin, M., Sioson, L., Toon, C., Clarkson, A., Watson, N., Pickett, J., Goodwin, A., Anderson, L., Clifton-Bligh, R., Dwight, T., Gill, A., et al (2016). Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings. American Journal of Surgical Pathology, 40(5), 599-607. [More Information]
  • McGrath, R., Preda, V., Clifton-Bligh, P., Robinson, B., Sywak, M., Delbridge, L., Ward, P., Clifton-Bligh, R., Learoyd, D. (2016). Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies? A large (Australian) cohort study in differentiated thyroid cancer. Clinical Endocrinology, 84(2), 271-277. [More Information]
  • Annamalai, A., Sampathkumar, K., Kane, S., Shetty, N., Kulkarni, S., Rangarajan, V., Purandare, N., Pai, P., Mahuvakar, A., et al, Gill, A., Clifton-Bligh, R. (2016). Needle(s) in the haystack- synchronous multifocal tumor induced osteomalacia. Journal of Clinical Endocrinology and Metabolism, 101(2), 390-393. [More Information]
  • Flynn, A., Dwight, T., Harris, J., Benn, D., Zhou, L., Hogg, A., Catchpoole, D., James, P., Duncan, E., Trainer, A., Gill, A., Clifton-Bligh, R., et al (2016). Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 101(4), 1034-1043. [More Information]
  • Martinez-Aguilar, J., Clifton-Bligh, R., Molloy, M. (2016). Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy. Scientific Reports, 6, 1-12. [More Information]
  • Bullock, M., Ren, Y., O’Neill, C., Gill, A., Aniss, A., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., de Vathaire, F., Robinson, B., Clifton-Bligh, R. (2016). TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas. Clinical Endocrinology, 85(2), 283-290. [More Information]

2015

  • Benn, D., Robinson, B., Clifton-Bligh, R. (2015). 15 Years of Paraganglioma: Clinical manifestations of paraganglioma syndromes types 1-5. Endocrine-Related Cancer, 22(4), T91-T103. [More Information]
  • Chou, A., Fraser, S., Toon, C., Clarkson, A., Sioson, L., Farzin, M., Cussigh, C., Aniss, A., O'Neill, C., Watson, N., Clifton-Bligh, R., Learoyd, D., Robinson, B., Delbridge, L., Sidhu, S., O'Toole, S., Sywak, M., Gill, A., et al (2015). A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma. American Journal of Surgical Pathology, 39(5), 652-659. [More Information]
  • Martinez-Aguilar, J., Clifton-Bligh, R., Molloy, M. (2015). A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours. BMC Cancer, 15(1), 1-14. [More Information]
  • Xing, M., Alzahrani, A., Carson, K., Shong, Y., Kim, T., Viola, D., Elisei, R., Bendlova, B., Yip, L., Mian, C., O'Neill, C., Sywak, M., Clifton-Bligh, R., et al (2015). Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer. Journal of Clinical Oncology, 33(1), 42-50. [More Information]
  • Cole, A., Clifton-Bligh, R., Marsh, D. (2015). Histone H2B monoubiquitination - roles to play in human malignancy. Endocrine-Related Cancer, 22(1), T19-T33. [More Information]
  • Elston, M., Meyer-Rochow, G., Conaglen, H., Clarkson, A., Clifton-Bligh, R., Conaglen, J., Gill, A. (2015). Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas. Human Pathology, 46(3), 390-396. [More Information]
  • Gundara, J., Gill, A., Glover, A., Benson, K., Clifton-Bligh, R., Roxburgh, S., Sywak, M. (2015). Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluation. ANZ Journal of Surgery, 85(4), 289-290. [More Information]
  • Clifton-Bligh, P., Nery,, M., Clifton-Bligh, R., Visvalingam, S., Fulcher, G., Byth Wilson, K., Baber, R. (2015). Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study. European Journal of Clinical Nutrition, 69(1), 134-142. [More Information]
  • Papathomas, T., Oudijk, L., Persu, A., Gill, A., van Nederveen, F., Tischler, A., Tissier, F., volante, M., Matias-Guiu, X., Smid, M., Clifton-Bligh, R., et al (2015). SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Modern Pathology, 28(6), 807-821. [More Information]
  • Mond, M., Bullock, M., Yao, Y., Clifton-Bligh, R., Gilfillan, C., Fuller, P. (2015). Somatic Mutations of FOXE1 in Papillary Thyroid Cancer. Thyroid, 25(8), 904-910. [More Information]
  • Kim, E., Rath, E., Tsang, V., Duff, A., Robinson, B., Church, W., Benn, D., Dwight, T., Clifton-Bligh, R. (2015). Structural and functional consequences of succinate dehydrogenase subunit B mutations. Endocrine-Related Cancer, 22(3), 387-397. [More Information]
  • Flynn, A., Benn, D., Clifton-Bligh, R., Robinson, B., Trainer, A., James, P., Hogg, A., Waldeck, K., George, J., Li, J., Gill, A., et al (2015). The genomic landscape of phaeochromocytoma. Journal of Pathology, 236(1), 78-89. [More Information]
  • Girgis, C., Cha, K., Houweling, P., Rao, R., Mokbel, N., Lin, M., Clifton-Bligh, R., Gunton, J. (2015). Vitamin D Receptor Ablation and Vitamin D Deficiency Result in Reduced Grip Strength, Altered Muscle Fibers, and Increased Myostatin in Mice. Calcified Tissue International, 97(6), 602-610. [More Information]

2014

  • Thompson, A., Turner, R., Hayen, A., Ahmad, A., Jalaty, S., Learoyd, D., Sidhu, S., Delbridge, L., Yeh, M., Clifton-Bligh, R., Sywak, M. (2014). A Pre-operative Nomogram for the Prediction of Ipsilateral Central Compartment Lymph Node Metastases in Papillary Thyroid Cancer. Thyroid, 24(4), 675-682. [More Information]
  • Schlosberg, A., Lam, B., Yeo, G., Clifton-Bligh, R. (2014). DEFLATE Compression Algorithm Corrects for Overestimation of Phylogenetic Diversity by Grantham Approach to Single-Nucleotide Polymorphism Classification. International Journal of Molecular Sciences, 15(5), 8491-8508. [More Information]
  • Lin, R., Gallagher, R., Spinaze, M., Najoumian, H., Dennis, C., Clifton-Bligh, R., Tofler, G. (2014). Effect of a Patient-Directed Discharge Letter on Patient Understanding of their Hospitalisation. Internal Medicine Journal, 44(9), 851-857. [More Information]
  • Girgis, C., Clifton-Bligh, R., Turner, N., Lau, S., Gunton, J. (2014). Effects of Vitamin D in Skeletal Muscle: Falls, Strength, Athletic Performance and Insulin Sensitivity. Clinical Endocrinology, 80(2), 169-181. [More Information]
  • Glendenning, P., Bell, D., Clifton-Bligh, R. (2014). Investigating hypophosphataemia. BMJ, 348, g3172. [More Information]
  • Gundara, J., Zhao, J., Gill, A., Clifton-Bligh, R., Robinson, B., Delbridge, L., Sidhu, S. (2014). Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ Journal of Surgery, 84(4), 235-239. [More Information]
  • Tsang, V., Dwight, T., Benn, D., Meyer-Rochow, G., Gill, A., Sywak, M., Sidhu, S., Veivers, D., Sue, C., Robinson, B., Clifton-Bligh, R., Parker, N. (2014). Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Endocrine-Related Cancer, 21(3), 415-426. [More Information]
  • Kruijff, S., Petersen, J., Chen, P., Aniss, A., Clifton-Bligh, R., Sidhu, S., Delbridge, L., Gill, A., Learoyd, D., Sywak, M. (2014). Patterns of Structural Recurrence in Papillary Thyroid Cancer. World Journal of Surgery, 38(3), 653-659. [More Information]
  • Parker, R., Clifton-Bligh, R., Molloy, M. (2014). Phosphoproteomics of MAPK inhibition in BRAF mutated cells and a role for the lethal synergism of dual BRAF and CK2 inhibition. Molecular Cancer Therapeutics, 13(7), 1894-1906. [More Information]
  • Paik, J., Toon, C., Benn, D., High, H., Hasovitz, C., Pavlakis, N., Clifton-Bligh, R., Gill, A. (2014). Renal Carcinoma Associated With Succinate Dehydrogenase B Mutation: A New and Unique Subtype of Renal Carcinoma. Journal of Clinical Oncology, 32(6), e10-e13. [More Information]
  • Gill, A., Hes, O., Papathomas, T., Šedivcová, M., Tan, P., Agaimy, A., Andresen, P., Kedziora, A., Clarkson, A., Toon, C., Sioson, L., Clifton-Bligh, R., Robinson, B., Benn, D., et al (2014). Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients. The American Journal of Surgical Pathology, 38(12), 1588-1602. [More Information]
  • Gill, A., Toon, C., Clarkson, A., Sioson, L., Chou, A., Winship, I., Robinson, B., Benn, D., Clifton-Bligh, R., Dwight, T. (2014). Succinate dehydrogenase deficiency is rare in pituitary adenomas. American Journal of Surgical Pathology, 38(4), 560-566. [More Information]
  • Girgis, C., Mokbel, N., Cha, K., Houweling, P., Abboud, M., Fraser, D., Mason, R., Clifton-Bligh, R., Gunton, J. (2014). The Vitamin D receptor (VDR) is Expressed in Skeletal Muscle of Male Mice and Modulates 25- Hydroxyvitamin D (25OHD) Uptake in myofibres. Endocrinology, 155(9), 3227-3237. [More Information]
  • Girgis, C., Clifton-Bligh, R., Mokbel, N., Cheng, K., Gunton, J. (2014). Vitamin D Signaling Regulates Proliferation, Differentiation and Myotube Size in C2C12 Skeletal Muscle Cells. Endocrinology, 155(2), 347-357. [More Information]
  • McInerney-Leo, A., Marshall, M., Gardiner, B., Benn, D., McFarlane, J., Robinson, B., Brown, M., Leo, P., Clifton-Bligh, R., Duncan, E. (2014). Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas. Clinical Endocrinology, 80(1), 25-33. [More Information]

2013

  • Xing, M., Alzahrani, A., Carson, K., Viola, D., Elisei, R., Bendlova, B., Yip, L., Mian, C., Vianello, F., Tuttle, M., O'Neill, C., Sywak, M., Clifton-Bligh, R., et al (2013). Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA, 309(14), 1493-1501. [More Information]
  • Kruijff, S., Aniss, A., Chen, P., Sidhu, S., Delbridge, L., Robinson, B., Clifton-Bligh, R., Roach, P., Gill, A., Learoyd, D., Sywak, M. (2013). Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery, 154(6), 1337-1345. [More Information]
  • Clifton-Bligh, R. (2013). Diagnosis of silent pheochromocytoma and paraganglioma. Expert Review of Endocrinology & Metabolism, 8(1), 47-57. [More Information]
  • Dwight, T., Mann, K., Benn, D., Robinson, B., McKelvie, P., Gill, A., Winship, I., Clifton-Bligh, R. (2013). Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 98(6), E1103-E1108. [More Information]
  • Gill, A., Lipton, L., Taylor, J., Benn, D., Richardson, A., Frydenberg, M., Shapiro, J., Clifton-Bligh, R., Chow, C., Bogwitz, M. (2013). Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma. Pathology, 45(7), 689-691. [More Information]
  • Clifton-Bligh, R., Hofman, M., Duncan, E., Sim, L., Darnell, D., Clarkson, A., Wong, T., Walsh, J., Gill, A., Ebeling, P., et al (2013). Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET/CT. Journal of Clinical Endocrinology and Metabolism, 98(2), 687-694. [More Information]
  • Dwight, T., Benn, D., Clarkson, A., Vilain, R., Lipton, L., Robinson, B., Clifton-Bligh, R., Gill, A. (2013). Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology, 37(2), 226-233. [More Information]
  • Ding, L., Shankara-Narayana, N., Wood, C., Ward, P., Sidhu, S., Clifton-Bligh, R. (2013). Markedly Elevated Serum Thyroglobulin Associated with Heterophile Antibodies: A Cautionary Tale. Thyroid, 23(6), 771-772. [More Information]
  • McCormack, A., Kaplan, W., Gill, A., Little, N., Cook, R., Robinson, B., Clifton-Bligh, R. (2013). MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary, 16(2), 208-219. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Glover, A., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2013). MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer, 119(24), 4358-4365. [More Information]
  • Gild, M., Clifton-Bligh, R., Robinson, B. (2013). Multiple Endocrine Neoplasia Type 2 and Bone. In Rajesh V Thakker, Michael P Whyte, John A Eisman, Takashi Igarashi (Eds.), Genetics of Bone Biology and Skeletal Disease, (pp. 505-513). London, United Kingdom: Academic Press.
  • Houang, M., Clarkson, A., Sioson, L., Elston, M., Clifton-Bligh, R., Dray, M., Ranchere-Vince, D., Decouvelaere, A., de la Fouchardiere, A., Gill, A. (2013). Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Human Pathology, 44(12), 2711-2718. [More Information]
  • Girgis, C., Clifton-Bligh, R., Hamrick, M., Holick, M., Gunton, J. (2013). The Roles of Vitamin D in Skeletal Muscle: Form, Function, and Metabolism. Endocrine Reviews, 34(1), 33-83. [More Information]

2012

  • Bullock, M., Duncan, E., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Ludgate, M., Clifton-Bligh, R. (2012). Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 97(9), e1814-e1819. [More Information]
  • Nguyen, T., Eisman, J., Center, J., Pocock, N., Jones, G., March, L., Clifton-Bligh, R., Naganathan, V., Seibel, M. (2012). In Memoriam: Philip Neil Sambrook. Osteoporosis International, 23(7), 1835-1836. [More Information]
  • Tsang, V., Parker, N., Cassano, J., Dwight, T., Sue, C., Veivers, D., Robinson, B., Benn, D., Clifton-Bligh, R. (2012). Interaction between hypoxia and mutations in the SDH subunit genes associated with phaeochromocytoma/paragangliomas. 2012 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology, Gold Coast, Queensland, Australia.
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2012). Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Annals of Surgical Oncology, 19(13), 4210-4216. [More Information]
  • Lin, R., Tofler, G., Spinaze, M., Dennis, C., Clifton-Bligh, R., Nojoumian, H., Gallagher, R. (2012). Patient-Directed Discharge Letter (PADDLE) - A Simple and brief intervention to improve patient knowledge and understanding at time of hospital discharge. 60th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ) 2012, Brisbane, Queensland, Australia. [More Information]
  • Jorgensen, N., Husted, L., Skarratt, K., Stokes, L., Tofteng, C., Kvist, T., Jensen, J., Eiken, P., Brixen, K., Fuller, S., Clifton-Bligh, R., Wiley, J., et al (2012). Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. European Journal of Human Genetics, 20(6), 675-681. [More Information]
  • Chou, A., Chen, J., Clarkson, A., Samra, J., Clifton-Bligh, R., Hugh, T., Gill, A. (2012). Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Modern Pathology, 25(9), 1307-1313. [More Information]
  • Bullock, M., O'Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]

2011

  • Clifton-Bligh, R., Nguyen, T., Au, A., Bullock, M., Cameron, I., Cumming, R., Chen, J., March, L., Seibel, M., Sambrook, P. (2011). Contribution of a Common Variant in the Promoter of the 1-a-Hydroxylase Gene (CYP27B1) to Fracture Risk in the Elderly. Calcified Tissue International, 88(2), 109-116. [More Information]
  • Tacon, L., Prichard, R., Soon, P., Robinson, B., Clifton-Bligh, R., Sidhu, S. (2011). Current and Emerging Therapies for Advanced Adrenocortical Carcinoma. The Oncologist, 16(1), 36-48. [More Information]
  • Gild, M., Bullock, M., Robinson, B., Clifton-Bligh, R. (2011). Multikinase inhibitors: a new option for the treatment of thyroid cancer. Nature Reviews Endocrinology, 7(10), 617-624. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clifton-Bligh, R. (2011). Pediatric-Type" Gastrointestinal Stromal Tumors Are SDHB Negative ("Type 2") GISTs.". American Journal of Surgical Pathology, 35(8), 1245-1247. [More Information]
  • Benaderet, A., Burton, A., Clifton-Bligh, R., ASHRAF, A. (2011). Primary Hyperparathyroidism with Low Intact PTH Levels in a 14-Year-Old Girl. Journal of Clinical Endocrinology and Metabolism, 96(8), 2325-2329. [More Information]
  • Gill, A., Pachter, N., Clarkson, A., Tucker, K., Winship, I., Benn, D., Robinson, B., Clifton-Bligh, R. (2011). Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. The New England Journal of Medicine, 364(9), 885-886. [More Information]
  • Gill, A., Pachter, N., Chou, A., Young, B., Clarkson, A., Tucker, K., Winship, I., Earls, P., Benn, D., Robinson, B., Clifton-Bligh, R., et al (2011). Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology. American Journal of Surgical Pathology, 35(10), 1578-1585. [More Information]

2010

  • O'Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]
  • Gill, A., Benn, D., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G., Richardson, A., Sidhu, S., Robinson, B., Clifton-Bligh, R. (2010). Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Human Pathology, 41(6), 805-814. [More Information]
  • Abraham, D., Delbridge, L., Clifton-Bligh, R., Clifton-Bligh, P., Grodski, S., Robinson, B., Messina, M., Sidhu, S. (2010). Medullary thyroid carcinoma presenting with an initial CEA elevation. ANZ Journal of Surgery, 80(11), 831-833. [More Information]
  • Meyer-Rochow, G., Jackson, N., Conaglen, J., Whittle, D., Kunnimalaiyaan, M., Chen, H., Westin, G., Sandgren, J., Stalberg, P., Khanafshar, E., Gill, A., Clifton-Bligh, R., Robinson, B., Benn, D., Sidhu, S., et al (2010). MicroRNA profiling of benign and malignant pheochromocytoma identifies novel diagnostic and therapeutic targets. Endocrine-Related Cancer, 17(3), 835-846. [More Information]

2009

  • Elston, M., Clifton-Bligh, R., Robinson, B. (2009). Familial pituitary tumor syndromes. Nature Reviews Endocrinology, 5(8), 453-61. [More Information]
  • McCormack, A., McDonald, K., Gill, A., Clark, S., Burt, M., Campbell, K., Braund, W., Little, N., Cook, R., Grossman, A., Robinson, B., Clifton-Bligh, R. (2009). Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clinical Endocrinology, 71(2), 226-233. [More Information]
  • Soon, P., Tacon, L., Gill, A., Bambach, C., Sywak, M., Campbell, P., Yeh, M., Wong, S., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research, 15(24), 7684-7692. [More Information]
  • Jack, M., Stone, M., Clifton-Bligh, R. (2009). Neonatal hypercalcemia due to polymorphisms of the calcium sensing receptor. Journal Of Pediatric Endocrinology and Metabolism, 22(6), 561-563. [More Information]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. (2009). Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas. Journal of Clinical Endocrinology and Metabolism, 94(4), 1436-1442. [More Information]
  • Meyer-Rochow, G., Soon, P., Delbridge, L., Sywak, M., Bambach, C., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ Journal of Surgery, 79(5), 367-370. [More Information]
  • Tacon, L., Soon, P., Gill, A., Chou, A., Clarkson, A., Botling, J., Stalberg, P., Skogseid, B., Robinson, B., Sidhu, S., Clifton-Bligh, R. (2009). The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 94(11), 4591-4599. [More Information]

2008

  • Lee, J., Au, A., Foukakis, T., Barbaro, M., Kiss, N., Clifton-Bligh, R., Staaf, J., Borg, A., Delbridge, L., Robinson, B., et al (2008). Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocrine-Related Cancer, 15(3), 801-815. [More Information]
  • Au, A., McDonald, K., Gill, A., Sywak, M., Diamond, T., Conigrave, A., Clifton-Bligh, R. (2008). PTH Mutation with Primary Hyperparathyroidism and Undetectable Intact PTH. New England Journal of Medicine, 359(11), 1184-1186. [More Information]

2006

  • Giordano, T., Au, A., Kuick, R., Thomas, D., Rhodes, D., Wilhelm, Jr., K., Vinco, M., Misek, D., Sanders, D., Zhu, Z., Clifton-Bligh, R., Robinson, B., et al (2006). Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical Cancer Research, 12(7), 1983-1993.
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. (2006). Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone, 39(2), 369-376. [More Information]
  • Au, A., McBride, C., Wilhelm, Jr., K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. (2006). PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology, 147(1), 367-376. [More Information]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. (2006). The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR gamma fusion. Journal of Clinical Endocrinology and Metabolism, 91(3), 1143-1149. [More Information]

2005

  • Mun, H., Culverston, E., Franks, A., Collyer, C., Clifton-Bligh, R., Conigrave, A. (2005). A double mutation in the extracellular Ca2+-sensing receptor's venus flytrap domain that selectively disables L-amino acid sensing. Journal of Biological Chemistry, 280(32), 29067-29072. [More Information]
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Nelson, A., Coyle, L., Ward, C., Clifton-Bligh, R., Robinson, B., Mason, R. (2005). Elevated serum FGF23 concentrations in plasma cell dyscrasias. 27th Annual Meeting of the American Society for Bone and Mineral Research, United States: American Society for Bone and Mineral Research.
  • Xue, M., Thompson, P., Clifton-Bligh, R., Fulcher, G., Gallery, E., Jackson, C. (2005). Leukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetes. The International Journal of Biochemistry and Cell Biology, 37(11), 2406-2416. [More Information]
  • Clifton-Bligh, R., Delbridge, L. (2005). Thyroid Physiology. In Clark, Orlo H.; Duh, Quan-Yang; Kebebew, Electron (Eds.), Textbook of endocrine surgery (2nd ed.). Philadelphia: Saunders Elsevier.

2004

  • Veitch, P., Clifton-Bligh, R. (2004). Long-acting sulfonylureas - long-acting hypoglycaemia. Medical Journal of Australia, 180(2), 84-85.

2003

  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Nelson, A., Clifton-Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jueppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., et al (2003). Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. Journal of Clinical Endocrinology and Metabolism, 88(9), 4088-4094.

To update your profile click here. For support on your academic profile contact .